[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 23.23.54.109. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Views 699
Citations 0
Comment & Response
October 22/29, 2014

Insulin vs Sulfonylureas for Second-Line Diabetes Treatment

Author Affiliations
  • 1Veterans Health Administration-Tennessee Valley Healthcare System Geriatric Research, Education Clinical Center, HSR&D Center, Nashville
  • 2Department of Biostatistics, Vanderbilt University, Nashville, Tennessee
  • 3Department of Health Policy, Vanderbilt University, Nashville, Tennessee
JAMA. 2014;312(16):1694. doi:10.1001/jama.2014.11126

To the Editor In Dr Safford’s Editorial,1 she discussed our analyses2 that quantified how sensitive our conclusions were to unmeasured confounding and used as an example the degree of insulin resistance. We would like to provide a clarification to the explanation provided regarding unmeasured confounder imbalance.

First Page Preview View Large
First page PDF preview
First page PDF preview
×